10-Q: Acme United Q3 2025: Sales Up, Net Income Down

Acme United Corporation reports mixed Q3 2025 results with increased net sales but a decline in net income, while addressing internal control weaknesses.

Summary

• Net sales for the three months ended September 30, 2025, increased 2% to $49.063 million compared to $48.166 million in the same period of 2024.
• Net sales for the nine months ended September 30, 2025, were $149.018 million, a slight increase from $148.547 million in the same period of 2024.
• Net income for the three months ended September 30, 2025, decreased to $1.903 million ($0.50 basic EPS) from $2.226 million ($0.60 basic EPS) in the prior year.
• Net income for the nine months ended September 30, 2025, was $8.308 million ($2.20 basic EPS), comparable to $8.315 million ($2.26 basic EPS) in the same period of 2024.
• Gross profit margin improved to 39.1% in Q3 2025 from 38.5% in Q3 2024, and to 39.8% for the nine months ended September 30, 2025, from 39.4% in the same period of 2024.
• Operating income for Q3 2025 increased to $3.007 million from $2.926 million in Q3 2024, while for the nine months, it slightly decreased to $11.824 million from $11.859 million.
• Working capital increased by approximately $4.0 million to $76.619 million during the first nine months of 2025, and the current ratio improved to 4.47.
• The long-term debt to equity ratio decreased to 24.0% at September 30, 2025, from 25.7% at December 31, 2024.
• A material weakness in information technology general controls (ITGCs) related to logical security and privileged access management was identified, with remediation expected by December 31, 2025.
• The company purchased a manufacturing and distribution center in Mt. Pleasant, TN for approximately $6.0 million on July 15, 2025.

Sentiment

Score: 5

Explanation: The company shows mixed financial results with slight revenue growth but a decline in Q3 net income and EPS. While liquidity metrics improved and debt maturity was extended, the identified material weakness in internal controls and ongoing geopolitical/tariff risks present concerns. The overall sentiment is neutral to slightly negative due to the net income decline and control weakness, balanced by improved balance sheet health.

Positives

• Net sales increased by 2% for the three months ended September 30, 2025, to $49.063 million.
• Gross profit margin improved to 39.1% in Q3 2025 from 38.5% in Q3 2024, and to 39.8% for the nine months ended September 30, 2025, from 39.4% in the same period of 2024.
• Operating income for Q3 2025 increased to $3.007 million from $2.926 million in Q3 2024.
• Interest expense, net, decreased by $113,000 for Q3 2025 and $295,000 for the nine months ended September 30, 2025, due to lower average outstanding borrowings and interest rates.
• Working capital increased by approximately $4.0 million to $76.619 million during the first nine months of 2025.
• Current ratio improved to 4.47 at September 30, 2025, from 4.17 at December 31, 2024.
• Long-term debt to equity ratio decreased to 24.0% at September 30, 2025, from 25.7% at December 31, 2024.
• The revolving credit facility maturity was extended to May 31, 2027.
• The company was in compliance with all loan covenants as of September 30, 2025.
• Strong sales of first aid products contributed to increased net sales in the U.S. and Canada.
• European net sales increased 13% in U.S. dollars for Q3 2025, driven by higher sales of school and office products into the e-commerce channel.

Negatives

• Net income for Q3 2025 decreased to $1.903 million from $2.226 million in Q3 2024, a 14.6% decline.
• Basic earnings per share decreased to $0.50 in Q3 2025 from $0.60 in Q3 2024.
• Diluted earnings per share decreased to $0.46 in Q3 2025 from $0.54 in Q3 2024.
• Net sales in the U.S. for the nine months ended September 30, 2025, decreased 1% compared to the same period in 2024.
• Sales of school and office products in the U.S. were lower in Q3 2025 due to the cancellation of customer orders as a result of tariff uncertainty.
• Selling, general and administrative expenses increased by $550,000 for Q3 2025 and $710,000 for the nine months ended September 30, 2025.
• Operating income for the nine months ended September 30, 2025, slightly decreased to $11.824 million from $11.859 million in the same period of 2024.
• Operating income in the European segment decreased by $363,000 for the nine months ended September 30, 2025.
• The effective income tax rate for Q3 2025 increased to 22% from 8% in Q3 2024, primarily due to a large excess tax benefit from stock option exercises in the prior year.
• Cash and cash equivalents decreased by $1.253 million for the nine months ended September 30, 2025.
• A material weakness in information technology general controls (ITGCs) was identified, indicating a control deficiency.

Risks

• Volatility in global economic conditions impacting suppliers and customers.
• International trade policies, including new tariffs, changes in existing tariff rates, or the threat of such actions, particularly concerning Chinese goods.
• Continuing adverse impact of inflation, including product costs, transportation costs, and interest rates.
• Potential adverse effects from geopolitical tensions and wars (Ukraine and Middle East) on the company, its customers, and suppliers.
• Additional disruptions in supply chains due to pandemics, natural disasters, trucker shortages, port closures, or strikes.
• Labor-related costs, including acquiring and training new employees and rising wages and benefits.
• Changes in client needs and consumer spending habits.
• Currency fluctuations.
• Ability to effectively manage inventory in a rapidly changing business environment.
• Impact of competition.
• Impact of technological changes including, specifically, the growth of online marketing and sales activity.
• Ability to manage growth effectively, including its ability to successfully integrate any business it might acquire.
• Material weakness in information technology general controls (ITGCs) related to logical security and privileged access management for a financially relevant system.

Future Outlook

The company believes that cash generated from operating activities, combined with available funds under its revolving loan agreement, will be sufficient to finance operations over the next twelve months. Remediation of the identified material weakness in internal controls is expected to be completed by December 31, 2025.

Management Comments

• "We have evaluated the effectiveness of our disclosure controls and procedures... Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were not effective as of September 30, 2025 as a result of an identified material weakness."
• "Management believes that, as a result of these changes [to internal control over financial reporting], the material weakness... will be remediated."
• "We expect that the remediation of this material weakness will be completed as of December 31, 2025."
• "The Company believes that cash generated from operating activities, together with funds available under its revolving loan agreement, will, under current conditions, be sufficient to finance the Companys operations over the next twelve months from the filing of this report."

Industry Context

The company operates in a global environment impacted by evolving trade policies, tariffs, and geopolitical tensions, which have led to inflationary costs. It is actively diversifying its supply base and adjusting pricing to mitigate these impacts. The increase in e-commerce sales for school and office products in Europe suggests a shift in consumer purchasing channels. The seasonal nature of the Westcott back-to-school market continues to influence sales and profits, with Q2 and Q3 traditionally stronger.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess the company's performance against global benchmarks. Therefore, a direct comparison to industry standards or specific competitors is not possible based solely on the provided document.

Corporate Governance

Legal Proceedings

• No pending material legal proceedings to which the company is a party, or, to the actual knowledge of the Company, contemplated by any governmental authority.

Stakeholder Impact

• Shareholders: Mixed impact due to increased sales but decreased Q3 net income and EPS. Improved liquidity and debt management are positive, but the internal control weakness is a concern. Dividends declared per share increased.
• Employees: Stock compensation expense is a factor in overall compensation. No direct impact on employment levels or benefits mentioned.
• Customers: Sales of first aid and medical products are strong, but school and office product sales were impacted by tariff uncertainty, suggesting potential supply or pricing issues for customers.
• Suppliers: The company is diversifying its supply base due to global trade policies and tariffs, which could shift business among suppliers.
• Creditors: The company is in compliance with loan covenants, and its current ratio and debt to equity ratio have improved, indicating a stable financial position for creditors.

Next Steps

• Remediation of the material weakness in information technology general controls (ITGCs) is expected to be completed by December 31, 2025.
• The company will continue to evaluate the impact of adopting ASU 2024-03 on its consolidated financial statements and related disclosures.

Key Dates

Recommendation

The company exhibits a stable financial position with improved liquidity metrics and a reduction in the debt-to-equity ratio. However, the decline in Q3 net income and EPS, coupled with the identified material weakness in internal controls, introduces uncertainty. While the company is actively addressing the control weakness and managing external risks like tariffs and inflation, the mixed performance and ongoing remediation efforts suggest a "hold" recommendation until the effectiveness of these measures is fully demonstrated and consistent earnings growth is re-established.

Keywords

First Aid, Medical Products, Cutting Tools, Sharpening Tools, SEC Filing, 10-Q, Quarterly Report, Financial Results, Corporate Governance, Risk Factors, Supply Chain, Tariffs, Inflation, E-commerce, Manufacturing, Distribution, ACU